This session explores the translation and application of pharmacogenomics to optimize drug treatment in the geriatric population. In addition, clinical applications of personalized oncology care with mismatch repair deficiency predicting response of tumors to PD-1 blockade and PARP inhibitors for cancer patients with BRCA mutations are reviewed.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 3/6/2023.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online NCPD evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Conferences Planning Committee Disclosures: No planning committee member discloses any actual or potential conflict of interest.
Speakers Conflict of Interest Disclosure: No speaker discloses any actual or potential conflict of interest.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).
Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.
Learning Outcome: After completing this learning activity, the participant will be able to discuss the translation and application of pharmacogenomics to optimize drug treatment in the geriatric population.
DNP, FNP-BC, AGN-BC, AOCNP, FAANP,
Vanderbilt University School of Nursing